Dietilkarbamazin sitrat’ın izole sıçan kalplerindeki etkileri ve etki mekanizmaları

Kaynakça (1)

1. Sanchez Bruni SF, Jones DG, Mckellar QA. Pharmacological approaches towards rationalizing the use of endoparasitic drugs in small animals. J Vet Pharmacol Ther 2006; 29: 443-57. [CrossRef] 2. Abaitey AK, Parratt JR. Cardiovascular effects of diethylcarbamazine citrate. Br J Pharmacol 1976; 56: 219-27. [CrossRef] 3. Ojewole JA, Onejeme IV. Myocardial depressant effects of diethylcarbamazine citrate in vitro. Eur J Pharmacol 1983; 87: 245-52. [CrossRef] 4. Hunsinger RN, Jenkins RL, Brown AL, Belew DH. Studies on the acute lethality of diethylcarbamazine in the rat. Vet Hum Toxicol 1993; 35: 11-5. 5. Doi Y, Masuyama T, Yamamoto K, Mano T, Naito J, Nagano R, et al. Coronary back flow pressure is elevated in association with increased left ventricular end-diastolic pressure in humans. Angiology 1996; 47: 1047-51. [CrossRef] 6. Kemp CD, Conte JV. The pathophysiology of heart failure. Cardiovasc Pathol 2012; 21: 365-71. [CrossRef] 7. Zhang Q, Scholz PM, He Y, Tse J, Weiss HR. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction. Cell Calcium 2005; 37: 259-66. [CrossRef] 8. Fujimaki Y, Sakamoto M, Shimada M, Kimura E, Aoki Y. Diethylcarbamazine: inhibitory effect on acetylcholinesterase of Dirofilaria immitis and Brugia pahangi. Southeast Asian J Trop Med Public Health 1989; 20: 179-82. 9. Bhattacharya C, Singh RN, Misra S, Rathaur S. Diethylcarbamazine; effect on lysosomal enzymes and acetylcholine in Wuchereria bancrofti infection. Trop Med Int Health 1997; 2: 686-90. [CrossRef] 10. Nadler E, Barnea O, Vidne B, Isakov A, Shavit G. Positive inotropic effect in the heart produced by acetylcholine. J Basic Clin Physiol Pharmacol 1993; 4: 229-48. [CrossRef]